Загрузка...
The “C3aR Antagonist” SB290157 is a Partial C5aR2 Agonist
Innate immune complement activation generates the C3 and C5 protein cleavage products C3a and C5a, defined classically as anaphylatoxins. C3a activates C3aR, while C5a activates two receptors (C5aR1 and C5aR2) to exert their immunomodulatory activities. The non-peptide compound, SB290157, was origin...
Сохранить в:
| Опубликовано в: : | Front Pharmacol |
|---|---|
| Главные авторы: | , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7859635/ https://ncbi.nlm.nih.gov/pubmed/33551801 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2020.591398 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|